XENON has been awarded NVIDIA's Partner of the Year at GTC2026, marking the third consecutive year the XENON team has ...

Shares of Xenon Pharmaceuticals (XENE) have gained approximately 20% over the past three months, primarily driven by positive ...

Canada’s most valuable drug developer is a B.C. company whose epilepsy treatment sharply reduces seizures in patients without causing an odd side effect from a similar drug shelved by GSK plc in 2017: ...

As part of a larger review, analyst Leonid Timashev identified 13 companies that could see deal interest as well as more than ...

This biotech specializes in clinical-stage therapies for neurological disorders, with a pipeline targeting epilepsy and ...

Xenon Pharmaceuticals’ phase 2 major depressive treatment did not show a statistically significant reduction in depression symptoms, failing a phase 2 trial. But management seems largely undeterred by ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." IF YOU COULD scale Everest and back in less than a week, would you do it? That's exactly what a British ...

VANCOUVER, British Columbia and BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, ...

The paradox of the missing xenon might sound like the title of the latest airport thriller, but it's actually a problem that's stumped geophysicists for decades. New work provides the first ...